KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,749 | -27.1% | 584 | -6.6% | 0.00% | 0.0% |
| Q2 2023 | $135,531 | -95.2% | 625 | -96.0% | 0.00% | -94.7% |
| Q1 2023 | $2,841,395 | +1.1% | 15,643 | +9.4% | 0.02% | -5.0% |
| Q4 2022 | $2,809,754 | -11.9% | 14,299 | +0.9% | 0.02% | -13.0% |
| Q3 2022 | $3,189,000 | +104.8% | 14,176 | +15.2% | 0.02% | +109.1% |
| Q2 2022 | $1,557,000 | +11.4% | 12,304 | +11.6% | 0.01% | +37.5% |
| Q1 2022 | $1,398,000 | -9.6% | 11,024 | -6.6% | 0.01% | 0.0% |
| Q4 2021 | $1,546,000 | +4.0% | 11,799 | -2.9% | 0.01% | 0.0% |
| Q3 2021 | $1,487,000 | +4.9% | 12,152 | -2.3% | 0.01% | +60.0% |
| Q2 2021 | $1,418,000 | +28.1% | 12,441 | +35.1% | 0.01% | +25.0% |
| Q1 2021 | $1,107,000 | +18.6% | 9,208 | +0.3% | 0.00% | +33.3% |
| Q4 2020 | $933,000 | +27.8% | 9,183 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $730,000 | -30.9% | 9,446 | -0.4% | 0.00% | -40.0% |
| Q2 2020 | $1,057,000 | +136.5% | 9,484 | +52.6% | 0.01% | +150.0% |
| Q1 2020 | $447,000 | +106.9% | 6,214 | +116.7% | 0.00% | +100.0% |
| Q4 2019 | $216,000 | +359.6% | 2,867 | -0.9% | 0.00% | – |
| Q3 2019 | $47,000 | – | 2,892 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |